Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database.
Shang Y, Wang X, Liu Y, Cheng W, Duan Y, Fang Z, Liu J, Kong F, Wang T, Yu T, Hu A, Zhang J, Zhang H, Li M, Rong Z, Li Y, Shakila SS, Li X, Feng J, Ma F, Guo B.
Shang Y, et al. Among authors: li y, li x, li m.
Breast Cancer. 2024 Jul;31(4):684-694. doi: 10.1007/s12282-024-01583-5. Epub 2024 Apr 21.
Breast Cancer. 2024.
PMID: 38643430
Free PMC article.